Organ Transplant Clinical Trials

26 recruitingLast updated: July 25, 2026

There are 26 actively recruiting organ transplant clinical trials across 14 countries. Studies span Not Applicable, Phase 4, Early Phase 1, Phase 2, Phase 1, Phase 3. Top locations include Boston, Massachusetts, United States, Pittsburgh, Pennsylvania, United States, Columbus, Ohio, United States. Updated daily from ClinicalTrials.gov.


Organ Transplant Trials at a Glance

26 actively recruiting trials for organ transplant are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Boston, Pittsburgh, and Columbus. Lead sponsors running organ transplant studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Pierre Fabre Medicament, and Francisco Hernández Oliveros.

Browse organ transplant trials by phase

Treatments under study

About Organ Transplant Clinical Trials

Looking for clinical trials for Organ Transplant? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Organ Transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Organ Transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 26 trials

Recruiting

Genome Transplant Dynamics

Thoracic Organ Transplantation
National Heart, Lung, and Blood Institute (NHLBI)991 enrolled6 locationsNCT02423070
Recruiting
Not Applicable

Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management

Organ Transplantation
University Hospital, Limoges430 enrolled4 locationsNCT03997253
Recruiting
Early Phase 1

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)+1 more
Marissa Lobl20 enrolled2 locationsNCT07286318
Recruiting
Phase 3

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament115 enrolled71 locationsNCT03394365
Recruiting
Not Applicable

Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.

Liver Transplant SurgerySolid-organ TransplantationDiabetes (Insulin-requiring, Type 1 or Type 2)+3 more
Institute for Clinical and Experimental Medicine62 enrolled1 locationNCT07611721
Recruiting

Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant

Organ Transplant
Western University, Canada30 enrolled2 locationsNCT05884736
Recruiting
Phase 1

Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients

Solid Organ Transplant ComplicationsSolid Organ Transplant RecipientsSolid Organ Transplant Rejection
Francisco Hernández Oliveros10 enrolled1 locationNCT06997471
Recruiting

Endothelial Glycocalyx Damage in Brain Death Organ Donors

Brain Damage Due to HypoxiaOrgan DonorsOrgan Transplant Failure or Rejection
University Hospital Hradec Kralove100 enrolled1 locationNCT05609123
Recruiting
Early Phase 1

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Allogeneic Hematopoietic Stem Cell Transplantation RecipientAdenovirusCytomegalovirus+2 more
Sumithira Vasu20 enrolled2 locationsNCT03665675
Recruiting

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

CancerMetabolic DiseaseChronic Kidney Diseases+3 more
University Hospital, Toulouse5,000 enrolled1 locationNCT05318196
Recruiting
Phase 2

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting
Phase 4

Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.

Solid Organ Transplant
Murdoch Childrens Research Institute45 enrolled1 locationNCT06529536
Recruiting
Phase 2

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914
Recruiting
Phase 4

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Liver Transplant; ComplicationsKidney Transplant; ComplicationsCytomegalovirus+2 more
Camille N. Kotton, MD80 enrolled2 locationsNCT06958796
Recruiting

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

Quality of LifePregnancyKidney Transplant+10 more
University Medical Center Groningen200 enrolled1 locationNCT07291258
Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Solid Organ TransplantHematopoietic Cell TransplantRespiratory Viral Infection
Arkansas Children's Hospital Research Institute2,000 enrolled27 locationsNCT05550298
Recruiting

Biomarkers in Transplant Recipients to Improve Outcomes

Bone Marrow TransplantationSolid-organ Transplantation
University of Pittsburgh1,200 enrolled1 locationNCT01163578
Recruiting
Not Applicable

iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients

Solid Organ Transplant
The Hospital for Sick Children55 enrolled1 locationNCT05968807
Recruiting
Phase 4

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

NeutropeniaCytomegalovirus InfectionsInfection in Solid Organ Transplant Recipients+1 more
Tufts Medical Center25 enrolled1 locationNCT05626530
Recruiting

The Organ Transplant Recipient HPV and Skin Cancer Study

Cervical CancerSkin CancerHPV-Related Malignancy+4 more
Merete Haedersdal1,500 enrolled3 locationsNCT05284877